BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Komajda M, Cowie MR, Tavazzi L, Ponikowski P, Anker SD, Filippatos GS; on behalf of the QUALIFY Investigators. Physicians' guideline adherence is associated with better prognosis in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry: Guideline adherence and outcomes in heart failure: QUALIFY. Eur J Heart Fail 2017;19:1414-23. [DOI: 10.1002/ejhf.887] [Cited by in Crossref: 119] [Cited by in F6Publishing: 118] [Article Influence: 23.8] [Reference Citation Analysis]
Number Citing Articles
1 Ward T, Brown T, Lewis RD, Kliess MK, de Arellano AR, Quinn CM. The Cost Effectiveness of Patiromer for the Treatment of Hyperkalaemia in Patients with Chronic Kidney Disease with and without Heart Failure in Ireland. Pharmacoecon Open 2022. [PMID: 35925491 DOI: 10.1007/s41669-022-00357-z] [Reference Citation Analysis]
2 Rosano GM, Seferovic P, Savarese G, Spoletini I, Lopatin Y, Gustafsson F, Bayes‐genis A, Jaarsma T, Abdelhamid M, Miqueo AG, Piepoli M, Tocchetti CG, Ristić AD, Jankowska E, Moura B, Hill L, Filippatos G, Metra M, Milicic D, Thum T, Chioncel O, Gal TB, Lund LH, Farmakis D, Mullens W, Adamopoulos S, Bohm M, Norhammar A, Bollmann A, Banerjee A, Maggioni AP, Voors A, Solal AC, Coats AJ. Impact analysis of heart failure across European countries: an ESC‐HFA position paper. ESC Heart Failure. [DOI: 10.1002/ehf2.14076] [Reference Citation Analysis]
3 Jan RK, Alsheikh-Ali A, Mulla AA, Sulaiman K, Panduranga P, Al-Mahmeed W, Bazargani N, Al-Suwaidi J, Al-Jarallah M, Al-Motarreb A, Salam A, Al-Zakwani I. Outcomes of guideline-based medical therapy in patients with acute heart failure and reduced left ventricular ejection fraction: Observations from the Gulf acute heart failure registry (Gulf CARE). Medicine (Baltimore) 2022;101:e29452. [PMID: 35687781 DOI: 10.1097/MD.0000000000029452] [Reference Citation Analysis]
4 Kim IC, Youn JC, Jang SY, Lee SE, Cho HJ, Choi JO, Lee JH, Kim KH, Lee SH, Kim KH, Lee JM, Yoo BS; SPARK study group. Physician adherence and patient-reported outcomes in heart failure with reduced ejection fraction in the era of angiotensin receptor-neprilysin inhibitor therapy. Sci Rep 2022;12:7730. [PMID: 35545653 DOI: 10.1038/s41598-022-11740-5] [Reference Citation Analysis]
5 Milinković I, Polovina M, Coats AJ, Rosano GM, Seferović PM. Medical Treatment of Heart Failure with Reduced Ejection Fraction in the Elderly. Card Fail Rev 2022;8:e17. [DOI: 10.15420/cfr.2021.14] [Reference Citation Analysis]
6 Granger BB, Kaltenbach LA, Fonarow GC, Allen LA, Lanfear DE, Albert NM, Al-Khalidi HR, Butler J, Cooper LB, DeWald T, Felker GM, Heidenreich P, Kottam A, Lewis EF, Piña IL, Yancy CW, Granger CB, Hernandez AF, DeVore AD. Health System-Level Performance in Prescribing Guideline-Directed Medical Therapy for Patients with HFrEF: Results from the CONNECT-HF Trial. J Card Fail 2022:S1071-9164(22)00489-4. [PMID: 35462033 DOI: 10.1016/j.cardfail.2022.03.356] [Reference Citation Analysis]
7 Davidson BT, Dunham S. The Perfect Storm. Critical Care Nursing Clinics of North America 2022. [DOI: 10.1016/j.cnc.2022.02.003] [Reference Citation Analysis]
8 Tomasoni D, Vishram-Nielsen JKK, Pagnesi M, Adamo M, Lombardi CM, Gustafsson F, Metra M. Advanced heart failure: guideline-directed medical therapy, diuretics, inotropes, and palliative care. ESC Heart Fail 2022. [PMID: 35352499 DOI: 10.1002/ehf2.13859] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Hafkamp FJ, Tio RA, Otterspoor LC, de Greef T, van Steenbergen GJ, van de Ven ART, Smits G, Post H, van Veghel D. Optimal effectiveness of heart failure management - an umbrella review of meta-analyses examining the effectiveness of interventions to reduce (re)hospitalizations in heart failure. Heart Fail Rev 2022. [PMID: 35239106 DOI: 10.1007/s10741-021-10212-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Wang Y, Schöbel C, Penzel T. Management of Obstructive Sleep Apnea in Patients With Heart Failure. Front Med 2022;9:803388. [DOI: 10.3389/fmed.2022.803388] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Villa C, Auerbach SR, Bansal N, Birnbaum BF, Conway J, Esteso P, Gambetta K, Hall EK, Kaufman BD, Kirmani S, Lal AK, Martinez HR, Nandi D, O'Connor MJ, Parent JJ, Raucci FJ, Shih R, Shugh S, Soslow JH, Tunuguntla H, Wittlieb-Weber CA, Kinnett K, Cripe L. Current Practices in Treating Cardiomyopathy and Heart Failure in Duchenne Muscular Dystrophy (DMD): Understanding Care Practices in Order to Optimize DMD Heart Failure Through ACTION. Pediatr Cardiol 2022. [PMID: 35024902 DOI: 10.1007/s00246-021-02807-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 James G, Kim J, Mellström C, Ford KL, Jenkins NC, Tsang C, Evans M, Mcewan P. Serum potassium variability as a predictor of clinical outcomes in patients with cardiorenal disease or diabetes: a retrospective UK database study. Clinical Kidney Journal 2021. [DOI: 10.1093/ckj/sfab225] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Ahmed KO, Taj Eldin I, Yousif M, Albarraq AA, Yousef BA, Ahmed N, Babiker A. Clinical Pharmacist's Intervention to Improve Medication Titration for Heart Failure: First Experience from Sudan. Integr Pharm Res Pract 2021;10:135-43. [PMID: 34796093 DOI: 10.2147/IPRP.S341621] [Reference Citation Analysis]
14 Rea F, Iorio A, Barbati G, Bessi R, Castrichini M, Nuzzi V, Scagnetto A, Senni M, Corrao G, Sinagra G, Di Lenarda A. Patient adherence to drug treatment in a community based-sample of patients with chronic heart failure. Int J Cardiol 2021:S0167-5273(21)01788-5. [PMID: 34801616 DOI: 10.1016/j.ijcard.2021.11.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Kahn M, Grayson AD, Chaggar PS, Ng Kam Chuen MJ, Scott A, Hughes C, Campbell NG. Primary care heart failure service identifies a missed cohort of heart failure patients with reduced ejection fraction. Eur Heart J 2021:ehab629. [PMID: 34508630 DOI: 10.1093/eurheartj/ehab629] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
16 Lin WY, Chung FP, Liao CT, Huang JL, Liang HW, Lee YH, Lin PL, Chiou WR, Hsu CY, Chang HY. Treatment with angiotensin receptor neprilysin inhibitor for Taiwan heart failure patients: Rationale and baseline characteristics of the TAROT-HF study. J Chin Med Assoc 2021;84:833-41. [PMID: 34524212 DOI: 10.1097/JCMA.0000000000000578] [Reference Citation Analysis]
17 Ghys LF, Martens P, Heggermont WA, Gabriel L, Heyse A, Troisfontaines P, Maris M. The in- and out-of-hospital management of HF patients: results from a nationwide Belgian survey. Acta Cardiol 2021;76:632-41. [PMID: 32507048 DOI: 10.1080/00015385.2020.1765105] [Reference Citation Analysis]
18 Sabouret P, Attias D, Beauvais C, Berthelot E, Bouleti C, Gibault Genty G, Galat A, Hanon O, Hulot JS, Isnard R, Jourdain P, Lamblin N, Lebreton G, Lellouche N, Logeart D, Meune C, Pezel T, Damy T. Diagnosis and management of heart failure from hospital admission to discharge: A practical expert guidance. Ann Cardiol Angeiol (Paris) 2021:S0003-3928(21)00068-8. [PMID: 34274113 DOI: 10.1016/j.ancard.2021.05.004] [Reference Citation Analysis]
19 Schumacher PM, Becker N, Tsuyuki RT, Griese-Mammen N, Koshman SL, McDonald MA, Bouvy M, Rutten FH, Laufs U, Böhm M, Schulz M. The evidence for pharmacist care in outpatients with heart failure: a systematic review and meta-analysis. ESC Heart Fail 2021. [PMID: 34240570 DOI: 10.1002/ehf2.13508] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
20 Milani RV, Lavie CJ, Ventura HO. New aspects in the management of hypertension in the digital era. Curr Opin Cardiol 2021;36:398-404. [PMID: 33871402 DOI: 10.1097/HCO.0000000000000870] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Savarese G, Bodegard J, Norhammar A, Sartipy P, Thuresson M, Cowie MR, Fonarow GC, Vaduganathan M, Coats AJS. Heart failure drug titration, discontinuation, mortality and heart failure hospitalization risk: a multinational observational study (US, UK and Sweden). Eur J Heart Fail 2021. [PMID: 34132001 DOI: 10.1002/ejhf.2271] [Cited by in Crossref: 4] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
22 Kobayashi M, Voors AA, Ouwerkerk W, Duarte K, Girerd N, Rossignol P, Metra M, Lang CC, Ng LL, Filippatos G, Dickstein K, van Veldhuisen DJ, Zannad F, Ferreira JP. Perceived risk profile and treatment optimization in heart failure: an analysis from BIOlogy Study to TAilored Treatment in chronic heart failure. Clin Cardiol 2021;44:780-8. [PMID: 33960439 DOI: 10.1002/clc.23576] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Shukkoor AA, George NE, Radhakrishnan S, Velusamy S, Kaliappan T, Gopalan R, Anandan P, Palanimuthu R, Balasubramanian VR. Impact of Clinical Audit on Adherence to the Guidelines Directed Medical Therapy in Patients Admitted with Heart Failure. Curr Drug Saf 2020;15:117-23. [PMID: 32156240 DOI: 10.2174/1574886315666200310114528] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
24 Hasin T, Davarashvili I, Michowitz Y, Farkash R, Presman H, Glikson M, Rav-Acha M. Association of Guideline-Based Medical Therapy with Malignant Arrhythmias and Mortality among Heart Failure Patients Implanted with Cardioverter Defibrillator (ICD) or Cardiac Resynchronization-Defibrillator Device (CRTD). J Clin Med 2021;10:1753. [PMID: 33920719 DOI: 10.3390/jcm10081753] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
25 Rapezzi C, Sinagra G, Merlo M, Ferrari R. The impossible interviews-Sherlock Holmes interviews David Sackett: 'how much can we trust the guidelines?'. Eur Heart J 2021:ehab187. [PMID: 33822035 DOI: 10.1093/eurheartj/ehab187] [Reference Citation Analysis]
26 Cowie MR, Schöpe J, Wagenpfeil S, Tavazzi L, Böhm M, Ponikowski P, Anker SD, Filippatos GS, Komajda M; QUALIFY Investigators. Patient factors associated with titration of medical therapy in patients with heart failure with reduced ejection fraction: data from the QUALIFY international registry. ESC Heart Fail 2021;8:861-71. [PMID: 33569926 DOI: 10.1002/ehf2.13237] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
27 Cardoso J, Espíndola MD, Cunha M, Netto E, Cardoso C, Novaes M, Del Carlo CH, Brancalhão E, Name AL, Barretto ACP. Is Current Drug Therapy for Heart Failure Sufficient to Control Heart Rate of Patients? Arq Bras Cardiol 2020;115:1063-9. [PMID: 33470302 DOI: 10.36660/abc.20190090] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
28 Greene SJ, Tan X, Yeh YC, Bernauer M, Zaidi O, Yang M, Butler J. Factors associated with non-use and sub-target dosing of medical therapy for heart failure with reduced ejection fraction. Heart Fail Rev 2021. [PMID: 33471236 DOI: 10.1007/s10741-021-10077-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 El Hadidi S, Vaughan C, Kerins D, Byrne S, Darweesh E, Bermingham M. Guideline-led prescribing to ambulatory heart failure patients in a cardiology outpatient service. Int J Clin Pharm 2021;43:1082-9. [PMID: 33411177 DOI: 10.1007/s11096-020-01220-z] [Reference Citation Analysis]
30 Verhestraeten C, Weijers G, Debleu D, Ciarka A, Goethals M, Droogmans S, Maris M. Diagnosis, treatment, and follow-up of heart failure patients by general practitioners: A Delphi consensus statement. PLoS One 2020;15:e0244485. [PMID: 33382755 DOI: 10.1371/journal.pone.0244485] [Reference Citation Analysis]
31 Feldman SF, Lesuffleur T, Olié V, Gastaldi-ménager C, Juillière Y, Tuppin P. French annual national observational study of 2015 outpatient and inpatient healthcare utilization by approximately half a million patients with previous heart failure diagnosis. Archives of Cardiovascular Diseases 2021;114:17-32. [DOI: 10.1016/j.acvd.2020.05.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Testa M, Cappuccio A, Latella M, Napolitano S, Milli M, Volpe M, Marini MG; TRUST participants. The emotional and social burden of heart failure: integrating physicians', patients', and caregivers' perspectives through narrative medicine. BMC Cardiovasc Disord 2020;20:522. [PMID: 33308152 DOI: 10.1186/s12872-020-01809-2] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
33 Tomasoni D, Adamo M, Anker MS, von Haehling S, Coats AJS, Metra M. Heart failure in the last year: progress and perspective. ESC Heart Fail. 2020;. [PMID: 33277825 DOI: 10.1002/ehf2.13124] [Cited by in Crossref: 7] [Cited by in F6Publishing: 22] [Article Influence: 3.5] [Reference Citation Analysis]
34 Russian Society of Cardiology (RSC) (. 2020 Clinical practice guidelines for Chronic heart failure. Russ J Cardiol 2020;25:4083. [DOI: 10.15829/1560-4071-2020-4083] [Cited by in Crossref: 63] [Cited by in F6Publishing: 13] [Article Influence: 31.5] [Reference Citation Analysis]
35 Rapezzi C, Lorenzini M. How far should guidelines be followed? Eur Heart J Suppl 2020;22:L121-3. [PMID: 33239985 DOI: 10.1093/eurheartj/suaa150] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
36 Bhatt NR, Czarniecki SW, Borgmann H, van Oort IM, Esperto F, Pradere B, van Gurp M, Bloemberg J, Darraugh J, Rouprêt M, Loeb S, N'Dow J, Ribal MJ, Giannarini G; EAU Guidelines Office Dissemination Committee. A Systematic Review of the Use of Social Media for Dissemination of Clinical Practice Guidelines. Eur Urol Focus 2020:S2405-4569(20)30292-3. [PMID: 33172773 DOI: 10.1016/j.euf.2020.10.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
37 Vatani Nezafat A, Tavakolifard N, Vaezi A. Adherence of General Practitioners to the National Hypertension Guideline, Isfahan, Iran. Int J Prev Med 2020;11:130. [PMID: 33088458 DOI: 10.4103/ijpvm.IJPVM_379_19] [Reference Citation Analysis]
38 Tereshchenko SN, Zhirov IV, Uskach TM, Saidova MA, Golitsyn SP, Gupalo EM, Nasonova SN, Narusov OY, Safiullina AA, Tereshchenko AS, Stukalova OV. EURASIAN ASSOCIATION OF CARDIOLOGY (EAC)/ NATIONAL SOCIETY OF HEART FAILURE AND MYOCARDIAL DISEASE (NSHFMD) GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF CHRONIC HEART FAILURE (2020). Evrazijskij kardiologičeskij žurnal 2020. [DOI: 10.38109/2225-1685-2020-3-6-76] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Grammatikopoulou MG, Theodoridis X, Gkiouras K, Lampropoulou M, Petalidou A, Patelida M, Tsirou E, Papoutsakis C, Goulis DG. Methodological quality of clinical practice guidelines for nutrition and weight gain during pregnancy: a systematic review. Nutr Rev 2020;78:546-62. [PMID: 31755916 DOI: 10.1093/nutrit/nuz065] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
40 El Hadidi S, Samir Bazan N, Byrne S, Darweesh E, Bermingham M. Heart Failure Prescribing Quality at Discharge from a Critical Care Unit in Egypt: The Impact of Multidisciplinary Care. Pharmacy (Basel) 2020;8:E159. [PMID: 32882858 DOI: 10.3390/pharmacy8030159] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
41 Oshikoya KA, Ogunyinka IA, Imuzei SE, Garba BI, Jiya NM. A Retrospective Audit of Pharmacologic and Non-Pharmacologic Management of Childhood Acute Asthma Exacerbation at Usmanu Danfodiyo University Teaching Hospital, Sokoto: Adherence to Global Treatment Guidelines. Front Pharmacol 2020;11:531894. [PMID: 32982749 DOI: 10.3389/fphar.2020.531894] [Reference Citation Analysis]
42 Fonseca C, Brito D, Branco P, Frazão JM, Silva-Cardoso J, Bettencourt P. Hyperkalemia and management of renin-angiotensin-aldosterone system inhibitors in chronic heart failure with reduced ejection fraction: A systematic review. Rev Port Cardiol (Engl Ed) 2020;39:517-41. [PMID: 32868174 DOI: 10.1016/j.repc.2020.03.015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
43 Stienen S, Bhatt A, Ferreira JP, Vaduganathan M, Januzzi J, Adams K, Tardif JC, Rossignol P, Zannad F. Bias in natriuretic peptide-guided heart failure trials: time to improve guideline adherence using alternative approaches. Heart Fail Rev 2021;26:11-21. [PMID: 32783110 DOI: 10.1007/s10741-020-10004-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
44 Wirtz HS, Sheer R, Honarpour N, Casebeer AW, Simmons JD, Kurtz CE, Pasquale MK, Globe G. Real-World Analysis of Guideline-Based Therapy After Hospitalization for Heart Failure. J Am Heart Assoc 2020;9:e015042. [PMID: 32805181 DOI: 10.1161/JAHA.119.015042] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
45 Barge-caballero E, Barge-caballero G, Couto-mallón D, Paniagua-martín MJ, Marzoa-rivas R, Naya-leira C, Riveiro-rodríguez CM, Grille-cancela Z, Blanco-canosa P, Muñiz J, Vázquez-rodríguez JM, Crespo-leiro MG. Comparación de mortalidad pronosticada y mortalidad observada en pacientes con insuficiencia cardiaca tratados en una unidad clínica especializada. Revista Española de Cardiología 2020;73:652-9. [DOI: 10.1016/j.recesp.2019.09.016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
46 Wachter R, Klebs S, Balas B, Kap E, Engelhard J, Schlienger R, Bruce Wirta S, Fonseca AF. Heart failure signs and symptoms, hospital referrals, and prescription patterns in patients receiving sacubitril/valsartan in primary care and cardiologist settings in Germany. ESC Heart Fail 2020;7:2318-30. [PMID: 33121216 DOI: 10.1002/ehf2.12768] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
47 Tomasoni D, Adamo M, Lombardi CM, Metra M. Highlights in heart failure. ESC Heart Fail 2019;6:1105-27. [PMID: 31997538 DOI: 10.1002/ehf2.12555] [Cited by in Crossref: 28] [Cited by in F6Publishing: 43] [Article Influence: 14.0] [Reference Citation Analysis]
48 Fernández-vázquez D, Ferrero-gregori A, Álvarez-garcía J, Gómez-otero I, Vázquez R, Delgado Jiménez J, Worner Diz F, Bardají A, García-pavía P, Bayés-genís A, González-juanatey JR, Cinca J, Pascual Figal DA. Cambio en la causa de muerte e influencia de la mejora terapéutica con el tiempo en pacientes con insuficiencia cardiaca y fracción de eyección reducida. Revista Española de Cardiología 2020;73:561-8. [DOI: 10.1016/j.recesp.2019.09.012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
49 Lombardi C, Peveri G, Cani D, Latta F, Bonelli A, Tomasoni D, Sbolli M, Ravera A, Carubelli V, Saccani N, Specchia C, Metra M. In-hospital and long-term mortality for acute heart failure: analysis at the time of admission to the emergency department. ESC Heart Fail 2020;7:2650-61. [PMID: 32588981 DOI: 10.1002/ehf2.12847] [Cited by in Crossref: 2] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
50 Ouwerkerk W, Teng TK, Tromp J, Tay WT, Cleland JG, Veldhuisen DJ, Dickstein K, Ng LL, Lang CC, Anker SD, Zannad F, Hung C, Sawhney JP, Naik A, Shimizu W, Hagiwara N, Wander GS, Anand I, Richards AM, Voors AA, Lam CS. Effects of combined renin–angiotensin–aldosterone system inhibitor and beta‐blocker treatment on outcomes in heart failure with reduced ejection fraction: insights from BIOSTAT‐CHF and ASIAN‐HF registries. Eur J Heart Fail 2020;22:1472-82. [DOI: 10.1002/ejhf.1869] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
51 Fekadu G, Bekele F, Bekele K, Hanbisa S, Belay G, Maqbool M. Drug Use Evaluation of Beta-Blockers in Medical Wards of Nedjo General Hospital, Western Ethiopia. Cardiovasc Ther 2020;2020:2509875. [PMID: 32565908 DOI: 10.1155/2020/2509875] [Reference Citation Analysis]
52 Leiva O, Bhatt AS, Vaduganathan M. Innovation in Ambulatory Care of Heart Failure in the Era of Coronavirus Disease 2019. Heart Fail Clin 2020;16:433-40. [PMID: 32888638 DOI: 10.1016/j.hfc.2020.06.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
53 Verhestraeten C, Heggermont WA, Maris M. Clinical inertia in the treatment of heart failure: a major issue to tackle. Heart Fail Rev 2020. [PMID: 32474794 DOI: 10.1007/s10741-020-09979-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
54 Bitar S, Thilly N, Agrinier N. Sustained adherence to ESC guideline‐recommended medications is associated with lower long‐term mortality in heart failure and reduced ejection fraction: Insights from the EPICAL2 cohort. J Clin Pharm Ther 2020;45:793-803. [DOI: 10.1111/jcpt.13176] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
55 Rossignol P, Williams B, Mayo MR, Warren S, Arthur S, Ackourey G, White WB, Agarwal R. Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): results in the pre-specified subgroup with heart failure. Eur J Heart Fail 2020;22:1462-71. [PMID: 32452085 DOI: 10.1002/ejhf.1860] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
56 Raafs AG, Linssen GCM, Brugts JJ, Erol-Yilmaz A, Plomp J, Smits JPP, Nagelsmit MJ, Oortman RM, Hoes AW, Brunner-LaRocca HP. Contemporary use of devices in chronic heart failure in the Netherlands. ESC Heart Fail 2020;7:1771-80. [PMID: 32395914 DOI: 10.1002/ehf2.12740] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
57 Goldgrab D, Balakumaran K, Kim MJ, Tabtabai SR. Updates in heart failure 30-day readmission prevention. Heart Fail Rev 2019;24:177-87. [PMID: 30488242 DOI: 10.1007/s10741-018-9754-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
58 Harjola V, Parissis J, Bauersachs J, Brunner‐la Rocca H, Bueno H, Čelutkienė J, Chioncel O, Coats AJ, Collins SP, Boer RA, Filippatos G, Gayat E, Hill L, Laine M, Lassus J, Lommi J, Masip J, Mebazaa A, Metra M, Miró Ò, Mortara A, Mueller C, Mullens W, Peacock WF, Pentikäinen M, Piepoli MF, Polyzogopoulou E, Rudiger A, Ruschitzka F, Seferovic P, Sionis A, Teerlink JR, Thum T, Varpula M, Weinstein JM, Yilmaz MB. Acute coronary syndromes and acute heart failure: a diagnostic dilemma and high‐risk combination. A statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2020;22:1298-314. [DOI: 10.1002/ejhf.1831] [Cited by in Crossref: 12] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
59 Kohl WK, Dobos G, Cramer H. Conventional and Complementary Healthcare Utilization Among US Adults With Cardiovascular Disease or Cardiovascular Risk Factors: A Nationally Representative Survey. J Am Heart Assoc 2020;9:e014759. [PMID: 32347141 DOI: 10.1161/JAHA.119.014759] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
60 Rossignol P, Lainscak M, Crespo-Leiro MG, Laroche C, Piepoli MF, Filippatos G, Rosano GMC, Savarese G, Anker SD, Seferovic PM, Ruschitzka F, Coats AJS, Mebazaa A, McDonagh T, Sahuquillo A, Penco M, Maggioni AP, Lund LH; Heart Failure Long-Term Registry Investigators Group. Unravelling the interplay between hyperkalaemia, renin-angiotensin-aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry. Eur J Heart Fail 2020;22:1378-89. [PMID: 32243669 DOI: 10.1002/ejhf.1793] [Cited by in Crossref: 50] [Cited by in F6Publishing: 37] [Article Influence: 25.0] [Reference Citation Analysis]
61 Spreafico M, Gasperoni F, Barbati G, Ieva F, Scagnetto A, Zanier L, Iorio A, Sinagra G, Di Lenarda A. Adherence to Disease-Modifying Therapy in Patients Hospitalized for HF: Findings from a Community-Based Study. Am J Cardiovasc Drugs 2020;20:179-90. [PMID: 31444666 DOI: 10.1007/s40256-019-00367-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
62 Seferović PM, Jankowska E, Coats AJS, Maggioni AP, Lopatin Y, Milinković I, Polovina M, Lainščak M, Timmis A, Huculeci R, Vardas P; Task Force of the HFA Atlas, and the ESC Atlas of Cardiology leadership, developed in collaboration with the National Heart Failure Societies of the ESC member and ESC affiliated member countries. The Heart Failure Association Atlas: rationale, objectives, and methods. Eur J Heart Fail 2020;22:638-45. [PMID: 32125085 DOI: 10.1002/ejhf.1768] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
63 Zubaid M, Rashed W, Ridha M, Bazargani N, Hamad A, Banna RA, Asaad N, Sulaiman K, Al-Jarallah M, Mulla AA, Baslaib F, AlMahmeed W. Implementation of Guideline-Recommended Therapies for Patients With Heart Failure and Reduced Ejection Fraction: A Regional Arab Middle East Experience. Angiology 2020;71:431-7. [PMID: 32066246 DOI: 10.1177/0003319720905742] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
64 Linssen GCM, Veenis JF, Kleberger A, Grosfeld MJW, Viergever EP, van Dalen BM, de Valk-Bedijn W, Langerveld J, Brunner-La Rocca HP, Hoes AW, Brugts JJ; CHECK-HF investigators. Medical treatment of octogenarians with chronic heart failure: data from CHECK-HF. Clin Res Cardiol 2020;109:1155-64. [PMID: 32030498 DOI: 10.1007/s00392-020-01607-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
65 Chang HY, Su YW, Feng AN, Fong MC, Huang KC, Chong E, Chen KC, Yin WH. Prescription patterns of diabetes medications influencing clinical outcomes of heart failure patients with reduced ejection fraction. ESC Heart Fail 2020;7:604-15. [PMID: 31995274 DOI: 10.1002/ehf2.12617] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
66 Lombardi CM, Ferreira JP, Carubelli V, Anker SD, Cleland JG, Dickstein K, Filippatos G, Lang CC, Ng LL, Ponikowski P, Samani NJ, van Veldhuisen DJ, Zannad F, Voors A, Metra M. Geographical differences in heart failure characteristics and treatment across Europe: results from the BIOSTAT-CHF study. Clin Res Cardiol 2020;109:967-77. [DOI: 10.1007/s00392-019-01588-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
67 Loring Z, Shrader P, Allen LA, Blanco R, Chan PS, Ezekowitz MD, Fonarow GC, Freeman JV, Gersh BJ, Mahaffey KW, Naccarelli GV, Pieper K, Reiffel JA, Singer DE, Steinberg BA, Thomas LE, Peterson ED, Piccini JP. Guideline-directed therapies for comorbidities and clinical outcomes among individuals with atrial fibrillation. Am Heart J 2020;219:21-30. [PMID: 31710841 DOI: 10.1016/j.ahj.2019.10.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
68 Hill L. Producing an effective care plan in advanced heart failure. Eur Heart J Suppl 2019;21:M61-3. [PMID: 31908620 DOI: 10.1093/eurheartj/suz213] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
69 Jankowska EA, Vitale C, Uchmanowicz I, Tkaczyszyn M, Drozd M, Ponikowski P. Drug therapy in elderly heart failure patients. Eur Heart J Suppl 2019;21:L8-L11. [PMID: 31885505 DOI: 10.1093/eurheartj/suz237] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
70 Rossignol P, Coats AJ, Chioncel O, Spoletini I, Rosano G. Renal function, electrolytes, and congestion monitoring in heart failure. Eur Heart J Suppl 2019;21:M25-31. [PMID: 31908612 DOI: 10.1093/eurheartj/suz220] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
71 Böhm M, Coats AJS, Kindermann I, Spoletini I, Rosano G. Physiological monitoring in the complex multimorbid heart failure patient - Conclusions. Eur Heart J Suppl 2019;21:M68-71. [PMID: 31908622 DOI: 10.1093/eurheartj/suz232] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
72 Angermann CE. The trialist's perspective: what do you need to prove for remote monitoring devices to be approved? Eur Heart J Suppl 2019;21:M57-60. [PMID: 31908619 DOI: 10.1093/eurheartj/suz214] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
73 Seferović PM. Introduction to the special issue entitled 'Heart failure management of the elderly patient: focus on frailty, sarcopenia, cachexia, and dementia'. Eur Heart J Suppl 2019;21:L1-3. [PMID: 31885503 DOI: 10.1093/eurheartj/suz234] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
74 Linde C, Bakhai A, Furuland H, Evans M, McEwan P, Ayoubkhani D, Qin L. Real-World Associations of Renin-Angiotensin-Aldosterone System Inhibitor Dose, Hyperkalemia, and Adverse Clinical Outcomes in a Cohort of Patients With New-Onset Chronic Kidney Disease or Heart Failure in the United Kingdom. J Am Heart Assoc 2019;8:e012655. [PMID: 31711387 DOI: 10.1161/JAHA.119.012655] [Cited by in Crossref: 12] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
75 Gilstrap LG, Stevenson LW, Small R, Parambi R, Hamershock R, Greenberg J, Carr C, Ghazinouri R, Rathman L, Han E, Mehra MR, Desai AS. Reasons for Guideline Nonadherence at Heart Failure Discharge. J Am Heart Assoc 2018;7:e008789. [PMID: 30371240 DOI: 10.1161/JAHA.118.008789] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 6.7] [Reference Citation Analysis]
76 Lenzi J, Avaldi VM, Molinazzi D, Descovich C, Urbinati S, Cappelli V, Fantini MP. Are degree of urbanisation and travel times to healthcare services associated with the processes of care and outcomes of heart failure? A retrospective cohort study based on administrative data. PLoS One 2019;14:e0223845. [PMID: 31658280 DOI: 10.1371/journal.pone.0223845] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
77 Zhang S, Zhou H, Zhuang X, Yang D, Sun X, Zhong X, Lin X, Hu X, Huang Y, Liao X, Du Z. Critical appraisal of guidelines for coronary artery disease on dual antiplatelet therapy: More consensus than controversies. Clin Cardiol 2019;42:1170-80. [PMID: 31609463 DOI: 10.1002/clc.23275] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
78 Caughey GE, Shakib S, Barratt JD, Roughead EE. Use of Medicines that May Exacerbate Heart Failure in Older Adults: Therapeutic Complexity of Multimorbidity. Drugs Aging 2019;36:471-9. [PMID: 30875020 DOI: 10.1007/s40266-019-00645-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
79 Krittayaphong R, Laothavorn P, Hengrussamee K, Sanguanwong S, Kunjara-Na-Ayudhya R, Rattanasumawong K, Komoltri C, Sritara P; Thai ADHERE Registry Group. Ten-year survival and factors associated with increased mortality in patients admitted for acute decompensated heart failure in Thailand. Singapore Med J 2020;61:320-6. [PMID: 31489430 DOI: 10.11622/smedj.2019108] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
80 Seferovic PM, Ponikowski P, Anker SD, Bauersachs J, Chioncel O, Cleland JGF, de Boer RA, Drexel H, Ben Gal T, Hill L, Jaarsma T, Jankowska EA, Anker MS, Lainscak M, Lewis BS, McDonagh T, Metra M, Milicic D, Mullens W, Piepoli MF, Rosano G, Ruschitzka F, Volterrani M, Voors AA, Filippatos G, Coats AJS. Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2019;21:1169-1186. [PMID: 31129923 DOI: 10.1002/ejhf.1531] [Cited by in Crossref: 260] [Cited by in F6Publishing: 295] [Article Influence: 86.7] [Reference Citation Analysis]
81 Hosseinzadeh-Shanjani Z, Hoveidamanesh S, Ramezani M, Davoudi F, Nojomi M. Adherence of cardiologist physicians to the American Heart Association guideline in approach to risk factors of cardiovascular diseases: An experience from a teaching hospital. ARYA Atheroscler 2019;15:38-43. [PMID: 31440284 DOI: 10.22122/arya.v15i1.1774] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
82 Di Palo KE, Piña IL, Ventura HO. Improving Provider Adherence to Guideline Recommendations in Heart Failure. Curr Heart Fail Rep 2018;15:350-6. [PMID: 30238398 DOI: 10.1007/s11897-018-0411-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
83 Ramalho SHR, Cipriano Junior G, Vieira PJC, Nakano EY, Winkelmann ER, Callegaro CC, Chiappa GR. Inspiratory muscle strength and six-minute walking distance in heart failure: Prognostic utility in a 10 years follow up cohort study. PLoS One 2019;14:e0220638. [PMID: 31369636 DOI: 10.1371/journal.pone.0220638] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
84 Metra M. July 2019 at a glance: imaging of congestion, sodium-glucose co-transporter 2 inhibitors, myocardial function and MitraClip trials. Eur J Heart Fail 2019;21:821-2. [PMID: 31353809 DOI: 10.1002/ejhf.1266] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
85 Bitar S, Agrinier N, Alla F, Rossignol P, Mebazaa A, Thilly N. Adherence to ESC guideline-recommended medications over a 36-month follow-up period after hospitalization for heart failure: Results from the EPICAL2 cohort study. Pharmacoepidemiol Drug Saf 2019;28:1489-500. [PMID: 31339629 DOI: 10.1002/pds.4868] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
86 Kleemann T, Strauss M, Kouraki K, Lampropoulou E, Fendt A, Werner N, Zahn R. Contemporary benefit-harm profile over two decades in primary prophylactic ICD-therapy. Clin Cardiol 2019;42:866-72. [PMID: 31317573 DOI: 10.1002/clc.23234] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
87 Milinković I, Polovina M, Seferović PM. Age old problem: heart failure treatment in elderly. Eur J Prev Cardiol 2019;26:1396-8. [PMID: 31161936 DOI: 10.1177/2047487319853643] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
88 Rossignol P, Hernandez AF, Solomon SD, Zannad F. Heart failure drug treatment. Lancet 2019;393:1034-44. [PMID: 30860029 DOI: 10.1016/S0140-6736(18)31808-7] [Cited by in Crossref: 99] [Cited by in F6Publishing: 37] [Article Influence: 33.0] [Reference Citation Analysis]
89 Sciatti E, Senni M, Lombardi CM, Gori M, Metra M. Sacubitril/valsartan: from a large clinical trial to clinical practice. J Cardiovasc Med (Hagerstown) 2018;19:473-9. [PMID: 29917003 DOI: 10.2459/JCM.0000000000000687] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
90 Wachter R, Fonseca AF, Balas B, Kap E, Engelhard J, Schlienger R, Klebs S, Wirta SB, Kostev K. Real-world treatment patterns of sacubitril/valsartan: a longitudinal cohort study in Germany. Eur J Heart Fail 2019;21:588-97. [PMID: 30972918 DOI: 10.1002/ejhf.1465] [Cited by in Crossref: 22] [Cited by in F6Publishing: 29] [Article Influence: 7.3] [Reference Citation Analysis]
91 Komajda M, Schöpe J, Wagenpfeil S, Tavazzi L, Böhm M, Ponikowski P, Anker SD, Filippatos GS, Cowie MR; QUALIFY Investigators. Physicians' guideline adherence is associated with long-term heart failure mortality in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry. Eur J Heart Fail 2019;21:921-9. [PMID: 30933403 DOI: 10.1002/ejhf.1459] [Cited by in Crossref: 42] [Cited by in F6Publishing: 53] [Article Influence: 14.0] [Reference Citation Analysis]
92 Fanaroff AC, Califf RM, Windecker S, Smith SC Jr, Lopes RD. Levels of Evidence Supporting American College of Cardiology/American Heart Association and European Society of Cardiology Guidelines, 2008-2018. JAMA 2019;321:1069-80. [PMID: 30874755 DOI: 10.1001/jama.2019.1122] [Cited by in Crossref: 94] [Cited by in F6Publishing: 82] [Article Influence: 31.3] [Reference Citation Analysis]
93 Veenis JF, Brunner-La Rocca HP, Linssen GC, Geerlings PR, Van Gent MW, Aksoy I, Oosterom L, Moons AH, Hoes AW, Brugts JJ; CHECK-HF investigators. Age differences in contemporary treatment of patients with chronic heart failure and reduced ejection fraction. Eur J Prev Cardiol 2019;26:1399-407. [PMID: 30866680 DOI: 10.1177/2047487319835042] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
94 Ihle P, Krueger K, Schubert I, Griese-Mammen N, Parrau N, Laufs U, Schulz M. Comparison of Different Strategies to Measure Medication Adherence via Claims Data in Patients With Chronic Heart Failure. Clin Pharmacol Ther 2019;106:211-8. [PMID: 30697693 DOI: 10.1002/cpt.1378] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
95 Trejo-Velasco B, Mateos-Pérez A. Guideline compliance: A cardiologist interview-based study. Eur J Prev Cardiol 2019;26:1564-7. [PMID: 30722678 DOI: 10.1177/2047487319826445] [Reference Citation Analysis]
96 Evans M, Palaka E, Furuland H, Bennett H, Linde C, Qin L, McEwan P, Bakhai A. The value of maintaining normokalaemia and enabling RAASi therapy in chronic kidney disease. BMC Nephrol 2019;20:31. [PMID: 30704421 DOI: 10.1186/s12882-019-1228-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
97 Dinatolo E, Sciatti E, Anker MS, Lombardi C, Dasseni N, Metra M. Updates in heart failure: what last year brought to us. ESC Heart Fail 2018;5:989-1007. [PMID: 30570225 DOI: 10.1002/ehf2.12385] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
98 Linde C, Qin L, Bakhai A, Furuland H, Evans M, Ayoubkhani D, Palaka E, Bennett H, McEwan P. Serum potassium and clinical outcomes in heart failure patients: results of risk calculations in 21 334 patients in the UK. ESC Heart Fail 2019;6:280-90. [PMID: 30629342 DOI: 10.1002/ehf2.12402] [Cited by in Crossref: 24] [Cited by in F6Publishing: 38] [Article Influence: 8.0] [Reference Citation Analysis]
99 Brunner-la Rocca H, Linssen GC, Smeele FJ, van Drimmelen AA, Schaafsma H, Westendorp PH, Rademaker PC, van de Kamp HJ, Hoes AW, Brugts JJ. Contemporary Drug Treatment of Chronic Heart Failure With Reduced Ejection Fraction. JACC: Heart Failure 2019;7:13-21. [DOI: 10.1016/j.jchf.2018.10.010] [Cited by in Crossref: 55] [Cited by in F6Publishing: 48] [Article Influence: 18.3] [Reference Citation Analysis]
100 Lopatin YM, Cowie MR, Grebennikova AA, Sisakian HS, Pagava ZM, Hayrapetyan HG, Abdullaev TA, Voronkov LG, Chesnikova AI, Tseluyko VI, Tarlovskaya EI, Dadashova GM, Berkinbaev SF, Glezer MG, Koziolova NA, Rakisheva AG, Kipiani ZV, Kurlyanskaya AK. Optimization of heart rate lowering therapy in hospitalized patients with heart failure: Insights from the Optimize Heart Failure Care Program. Int J Cardiol 2018;260:113-7. [PMID: 29622423 DOI: 10.1016/j.ijcard.2017.12.093] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
101 Atherton JJ, Sindone A, De Pasquale CG, Driscoll A, Macdonald PS, Hopper I, Kistler PM, Briffa T, Wong J, Abhayaratna W, Thomas L, Audehm R, Newton P, O'loughlin J, Branagan M, Connell C. National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Guidelines for the Prevention, Detection, and Management of Heart Failure in Australia 2018. Heart, Lung and Circulation 2018;27:1123-208. [DOI: 10.1016/j.hlc.2018.06.1042] [Cited by in Crossref: 122] [Cited by in F6Publishing: 99] [Article Influence: 30.5] [Reference Citation Analysis]
102 Koehler F, Koehler K, Deckwart O, Prescher S, Wegscheider K, Winkler S, Vettorazzi E, Polze A, Stangl K, Hartmann O, Marx A, Neuhaus P, Scherf M, Kirwan BA, Anker SD. Telemedical Interventional Management in Heart Failure II (TIM-HF2), a randomised, controlled trial investigating the impact of telemedicine on unplanned cardiovascular hospitalisations and mortality in heart failure patients: study design and description of the intervention. Eur J Heart Fail 2018;20:1485-93. [PMID: 30230666 DOI: 10.1002/ejhf.1300] [Cited by in Crossref: 34] [Cited by in F6Publishing: 39] [Article Influence: 8.5] [Reference Citation Analysis]
103 Bakhai A, Palaka E, Linde C, Bennett H, Furuland H, Qin L, McEwan P, Evans M. Development of a health economic model to evaluate the potential benefits of optimal serum potassium management in patients with heart failure. J Med Econ 2018;21:1172-82. [PMID: 30160541 DOI: 10.1080/13696998.2018.1518239] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
104 Furuland H, McEwan P, Evans M, Linde C, Ayoubkhani D, Bakhai A, Palaka E, Bennett H, Qin L. Serum potassium as a predictor of adverse clinical outcomes in patients with chronic kidney disease: new risk equations using the UK clinical practice research datalink. BMC Nephrol 2018;19:211. [PMID: 30134846 DOI: 10.1186/s12882-018-1007-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
105 Cotter G, Davison BA. Unmodifiable events, heart failure research, and ‘risk‐based monitoring’ in large studies—the unholy triumvirate. Eur J Heart Fail 2018;20:1639-44. [DOI: 10.1002/ejhf.1282] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
106 Crespo-leiro MG, Metra M, Lund LH, Milicic D, Costanzo MR, Filippatos G, Gustafsson F, Tsui S, Barge-caballero E, De Jonge N, Frigerio M, Hamdan R, Hasin T, Hülsmann M, Nalbantgil S, Potena L, Bauersachs J, Gkouziouta A, Ruhparwar A, Ristic AD, Straburzynska-migaj E, Mcdonagh T, Seferovic P, Ruschitzka F. Advanced heart failure: a position statement of the Heart Failure Association of the European Society of Cardiology: Advanced heart failure: HFA position statement. Eur J Heart Fail 2018;20:1505-35. [DOI: 10.1002/ejhf.1236] [Cited by in Crossref: 217] [Cited by in F6Publishing: 263] [Article Influence: 54.3] [Reference Citation Analysis]
107 Pepió Vilaubí JM, Orozco-Beltrán D, Gonçalves AQ, Rodriguez Cumplido D, Aguilar Martin C, Lopez-Pineda A, Gil-Guillen VF, Quesada JA, Carratala-Munuera C. Adherence to European Clinical Practice Guidelines for Secondary Prevention of Cardiovascular Disease: A Cohort Study. Int J Environ Res Public Health 2018;15:E1233. [PMID: 29891821 DOI: 10.3390/ijerph15061233] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
108 Hood SR, Giazzon AJ, Seamon G, Lane KA, Wang J, Eckert GJ, Tu W, Murray MD. Association Between Medication Adherence and the Outcomes of Heart Failure. Pharmacotherapy 2018;38:539-45. [DOI: 10.1002/phar.2107] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 5.3] [Reference Citation Analysis]
109 Sood A, Dobbie K, Wilson Tang WH. Palliative Care in Heart Failure. Curr Treat Options Cardiovasc Med 2018;20:43. [PMID: 29671078 DOI: 10.1007/s11936-018-0634-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
110 García-pinilla JM, Farrero Torres M, González-vílchez F, Barge Caballero E, Masip J, Segovia Cubero J. Selección de lo mejor del año 2017 en insuficiencia cardiaca aguda y crónica. Revista Española de Cardiología 2018;71:298-9. [DOI: 10.1016/j.recesp.2017.11.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
111 Brugts JJ, Linssen GCM, Hoes AW, Brunner-La Rocca HP; CHECK-HF investigators. Real-world heart failure management in 10,910 patients with chronic heart failure in the Netherlands : Design and rationale of the Chronic Heart failure ESC guideline-based Cardiology practice Quality project (CHECK-HF) registry. Neth Heart J 2018;26:272-9. [PMID: 29564639 DOI: 10.1007/s12471-018-1103-7] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
112 Ferrari R, Bueno H, Chioncel O, Cleland JG, Stough WG, Lettino M, Metra M, Parissis JT, Pinto F, Ponikowski P, Ruschitzka F, Tavazzi L. Acute heart failure: lessons learned, roads ahead: Viewpoint. Eur J Heart Fail 2018;20:842-50. [DOI: 10.1002/ejhf.1169] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
113 Ambrosy AP, Fudim M, Chioncel O. Sudden cardiac death following admission for acute heart failure: adding insult to injury. Eur J Heart Fail 2018;20:533-5. [PMID: 29314460 DOI: 10.1002/ejhf.1109] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
114 Lund LH, Køber L, Swedberg K, Ruschitzka F. The year in cardiology 2017: heart failure. European Heart Journal 2018;39:832-9. [DOI: 10.1093/eurheartj/ehx782] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
115 Metra M. November 2017 at a glance: quality of care and disease management. Eur J Heart Fail 2017;19:1351-2. [PMID: 29143470 DOI: 10.1002/ejhf.1074] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
116 Ambrosy AP, Gheorghiade M. Real-world dosing of evidence-based medications for heart failure: embracing guideline recommendations and clinical judgement: Editorial comment. Eur J Heart Fail 2017;19:1424-6. [DOI: 10.1002/ejhf.915] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
117 Störk S, Handrock R, Jacob J, Walker J, Calado F, Lahoz R, Hupfer S, Klebs S. Treatment of chronic heart failure in Germany: a retrospective database study. Clin Res Cardiol 2017;106:923-32. [PMID: 28748266 DOI: 10.1007/s00392-017-1138-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
118 Cowie MR, Komajda M. Quality of Physician Adherence to Guideline Recommendations for Life-saving Treatment in Heart Failure: an International Survey. Card Fail Rev 2017;3:130-3. [PMID: 29387466 DOI: 10.15420/cfr.2017:13:1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]